Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6484)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2014 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Nam HH, Jun DW, Jeon HJ, Lee JS, Saeed WK, Kim EK. Osthol attenuates hepatic steatosis |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i33/11753.htm |
| Number | Citing Articles |
| 1 |
Maria Hernandez-Rodas, Rodrigo Valenzuela, Luis Videla. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(10): 25168 doi: 10.3390/ijms161025168
|
| 2 |
Nesrine Semiane, Fabienne Foufelle, Pascal Ferré, Isabelle Hainault, Souad Ameddah, Aicha Mallek, Ali Khalkhal, Yasmina Dahmani. High carbohydrate diet induces nonalcoholic steato-hepatitis (NASH) in a desert gerbil
. Comptes Rendus. Biologies 2016; 340(1): 25 doi: 10.1016/j.crvi.2016.09.002
|
| 3 |
Xu-Jia Chen, Wen-Jing Liu, Meng-Liang Wen, Hong Liang, Shao-Mei Wu, Yun-Zhen Zhu, Jiang-Yuan Zhao, Xiang-Qian Dong, Ming-Gang Li, Li Bian, Cheng-Gang Zou, Lan-Qing Ma. Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats. Scientific Reports 2017; 7(1) doi: 10.1038/srep41144
|
| 4 |
Chek Kun Tan, Yan Zhuang, Walter Wahli. Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome. Expert Opinion on Therapeutic Targets 2017; 21(3): 333 doi: 10.1080/14728222.2017.1280467
|
| 5 |
Natalia Karolina Kordulewska, Elżbieta Kostyra, Michał Matysiewicz, Anna Cieślińska, Beata Jarmołowska. Impact of fexofenadine, osthole and histamine on peripheral blood mononuclear cell proliferation and cytokine secretion. European Journal of Pharmacology 2015; 761: 254 doi: 10.1016/j.ejphar.2015.05.065
|
| 6 |
Seung Min Lee, Dae Won Jun. Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”. Clinical and Molecular Hepatology 2023; 29(1): 171 doi: 10.3350/cmh.2022.0381
|
| 7 |
Schohraya Spahis, Edgard Delvin, Jean-Michel Borys, Emile Levy. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis. Antioxidants & Redox Signaling 2017; 26(10): 519 doi: 10.1089/ars.2016.6776
|
| 8 |
Shakti Prasad Pattanayak, Pritha Bose, Priyashree Sunita, Mohd Usman Mohd Siddique, Antonio Lapenna. Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways. Biomedicine & Pharmacotherapy 2018; 108: 297 doi: 10.1016/j.biopha.2018.08.145
|
| 9 |
Xiang Qiu, Dan-Hong Gao, Xiao Xiang, Yu-Fang Xiong, Teng-Shi Zhu, Lie-Gang Liu, Xiu-Fa Sun, Li-Ping Hao. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. World Journal of Gastroenterology 2015; 21(26): 8061-8072 doi: 10.3748/wjg.v21.i26.8061
|
| 10 |
Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim. Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways. Clinical and Molecular Hepatology 2022; 28(4): 827 doi: 10.3350/cmh.2022.0068
|
| 11 |
Ya-Wei Liu, Yung-Tsung Chiu, Shu-Ling Fu, Yi-Tsau Huang. Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation. Journal of Biomedical Science 2015; 22(1) doi: 10.1186/s12929-015-0168-5
|
| 12 |
Wen-Chung Huang, Po-Chen Liao, Chun-Hsun Huang, Sindy Hu, Shih-Chun Huang, Shu-Ju Wu. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells. Biomedicine & Pharmacotherapy 2017; 91: 78 doi: 10.1016/j.biopha.2017.04.051
|
| 13 |
JUAN DUAN, YU YANG, HONG LIU, PENG-CHENG DOU, SHENG-YU TAN. Osthole ameliorates acute myocardial infarction in rats by decreasing the expression of inflammatory-related cytokines, diminishing MMP-2 expression and activating p-ERK. International Journal of Molecular Medicine 2016; 37(1): 207 doi: 10.3892/ijmm.2015.2402
|